RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 76.25
-8.75 (-10.29%)
Jul 17, 2026, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 63.31 billion as of July 17, 2026. Its market cap has increased by 56.25% in one year.
Market Cap
63.31B
Enterprise Value
62.57B
Revenue
3.84B
Ranking
n/a
PE Ratio
28.74
Stock Price
76.25
ChartMarket Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 63.31B, an increase of 89.60%. That is a compound annual growth rate of 11.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 63.31B | 40.06% |
| Dec 31, 2025 | 45.20B | 222.75% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 154.85B |
| WuXi Biologics | 151.76B |
| Sichuan Kelun-Biotech Biopharmaceutical | 116.26B |
| Sino Biopharmaceutical | 88.67B |
| Akeso | 81.38B |
| Biocytogen Pharmaceuticals (Beijing) | 61.46B |
| 3SBio | 40.39B |
| Shanghai Junshi Biosciences | 35.67B |